# Carisma Therapeutics, Inc. (CARM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CARM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 50.15M | $ 26.29M | $ -14.40M | $ 762.0K | $ -867.0K |
| 2024 | $ 20.63M | $ -63.57M | $ -63.11M | $ 2.48M | $ -27.91M |
| 2023 | $ 16.13M | $ -93.94M | $ -89.00M | $ 3.12M | $ 26.53M |
| 2022 | $ 10.99M | $ -68.40M | $ -13.66M | $ 40.16M | $ -157.07M |
| 2021 | $ 31.55M | $ -78.34M | $ -81.88M | $ 2.63M | $ 171.71M |
| 2020 | $ 14.31M | $ -28.53M | $ -28.03M | $ 0 | $ -9.23M |
| 2019 | $ 0 | $ -138.76M | $ -48.55M | $ 0 | $ -26.70M |
| 2018 | $ 0 | $ -44.50M | $ -30.15M | $ 0 | $ 44.21M |
| 2017 | $ 572.5K | $ -39.11M | $ -23.93M | $ 0 | $ 18.03M |
| 2016 | $ 41.25M | $ 2.26M | $ 3.61M | $ 0 | $ 38.68M |
| 2015 | $ 1.39M | $ -48.93M | $ -48.88M | $ 13.90M | $ 18.94M |
| 2014 | $ 3.17M | $ -48.79M | $ -41.60M | $ 10.00M | $ 36.83M |
| 2013 | $ 1.90M | $ -27.63M | $ -19.19M | $ 4.52M | $ 2.35M |
| 2012 | $ 0 | $ -7.42M | $ -7.01M | $ 2.01M | $ 5.74M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.88 |
| Liabilities / Eq | -8.56 |
| Current Ratio | 0.86 |

## Other views

- [Metrics](https://sponda.capital/en/CARM.md)
- [Charts](https://sponda.capital/en/CARM/charts.md)
- [Compare](https://sponda.capital/en/CARM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.